Printer Friendly
The Free Library
14,715,713 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Merck wins.


Merck Wins: A Los Angeles Los Angeles (lôs ăn`jələs, lŏs, ăn`jəlēz'), city (1990 pop. 3,485,398), seat of Los Angeles co., S Calif.; inc. 1850.  jury gave Merck & Co. Inc. another court victory last week when it found the withdrawn pain medicine Vioxx Vi·oxx

A trademark for the drug rofecoxib.


Vioxx® Rofecoxib Pain management A COX-2 inhibitor used to manage osteoarthritic pain, acute pain in adults, primary dysmenorrhea.
See COX-2 inhibitor.
 did not cause the heart attack of a 71-year-old retired construction manager. Merck has now won five of the eight Vioxx suits that have been decided in court, the company said. The Los Angeles case, the first Vioxx lawsuit lawsuit: see procedure; tort.  to go to trial in California California (kăl'ĭfôr`nyə), most populous state in the United States, located in the Far West; bordered by Oregon (N), Nevada and, across the Colorado River, Arizona (E), Mexico (S), and the Pacific Ocean (W). , was brought by Stewart Grossberg, who started taking Vioxx in 1999. He suffered a heart attack in 2001. Merck said it is facing at least 14,200 lawsuits from people who claim to have been harmed by Vioxx. The drug was pulled from the market in September 2004.
COPYRIGHT 2006 CBJ, L.P.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Merck and Company Inc. wins a lawsuit filed by Stewart Grossberg on the adverse affects of the company's Vioxx
Comment:Merck wins.(Merck and Company Inc. wins a lawsuit filed by Stewart Grossberg on the adverse affects of the company's Vioxx)
Publication:Los Angeles Business Journal
Article Type:Brief article
Geographic Code:1USA
Date:Aug 7, 2006
Words:116
Previous Article:Activision probe.(News of the Week)
Next Article:Cold topic.(Hot Topic Inc.'s sales and stocks drops)(Brief article)
Topics:



Related Articles
New Cox-2 pain relievers are marketing marvel, not miracle drugs.
New resources aid Vioxx plaintiffs and their lawyers.
Merck's heart attack.(Editorials)(Vioxx verdict is marketing's boomerang)(Editorial)
Viewing the Vioxx verdict: suits become sole protection against big pharma firms.(COMMENTARY)
Vioxx lawyers to carry heavy caseloads.(DRUGMAKERS UNDER FIRE)(Merck and Company Inc.)
Judge lets Vioxx lawyers discuss FDA memo.(Food and Drug Administration )
Vying for Vioxx.(California residents sue Merck & Co.)(Brief Article)
Judge finds answer to Court TV quandary on the Web.(LAW)(Brief article)
Vioxx studies question timing of heart attack risk.
Embracing risk factors in pharmaceutical litigation: plaintiff lawyers tend to be reluctant to take on a drug injury case unless the client has few...

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles